Hadjigapor, Aljavar C.

HRN: 16-18-01  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2025
CEFUROXIME 750MG (VIAL)
07/25/2025
08/01/2025
IV
750mg
Q8H
URTI
Checking Initial Appropriateness 
07/27/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/27/2025
08/06/2025
PO
12 Ml
Q 8 Hours
Intestinal Amoebiasis
Checking Initial Appropriateness 
07/30/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
07/30/2025
08/06/2025
ORAL
4ml
QID
Oral Thrush
Checking Initial Appropriateness 
07/30/2025
CEFTRIAXONE 1G (VIAL)
07/29/2025
08/05/2025
IV
2g
OD
URTI
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: